PPT-Ebola Virus Disease and

Clinical Care Part III Experimental Treatments and Vaccines US Department of Health and Human Services Centers for Disease Control and Prevention This presentation is current as of December 2014 This . (EVD). جمع آوری توسط:. دکتر احمد رضا مبیّن. متخصص بیماریهای عفونی. اسفند ماه 1393. Ebola . was first discovered in . 1976 near the Ebola River . in what is now the Democratic Republic of the . Virus . Disease: treatment, gaps and options. Ellis Owusu-Dabo . (BSc, MB ChB. , MSc, PhD, MWACP, FGCP) . Director, . KCCR/KNUST, Kumasi. , . Ghana . www.kccr-ghana.org. . Established in . October 1997. Where did they get it?. How do you get the virus? . The EBOLA Health Commissioner. The EBOLA Health Commissioner . Understand science of disease and its transmission. Interrupt the transmission of the virus. Jeffrey Hoogheem. Texas Department of State Health Services. Introduction. The 2014 Ebola incident was historic and unlike anything we have faced before. Many of the challenges were not unique to Dallas or the state of Texas. What is a Virus?. Viruses are microscopic particles (10 – 400 nm).. Viruses are made of genetic material (DNA or RNA) surrounded by a protein coating and sometimes an outer layer containing lipids.. Type of Disease:. The . Ebola virus is classified under the Filovirus family. . There . are also four types of the Ebola virus: Ebola-Zaire, Ebola-Sudan, Ebola-Ivory Coast(Tai), and Ebola-Reston.. Description of Disease:. 2014 Ebola Virus Outbreak What is a Virus? Viruses are microscopic particles (10 – 400 nm). Viruses are made of genetic material (DNA or RNA) surrounded by a protein coating and sometimes an outer layer containing lipids. Part I: . History, Transmission, and Clinical Presentation. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. This presentation is current . as of . December . A . virus. . is a small infectious agent replicating . inside. the . living. cells of the . host. . organism. Life cycle: Attachment > Insertion > Replication > Assembly > Lysis and Release. spread through direct contact (through broken skin or mucous membranes) with infected blood and body fluids . not spread through the air or by water. Individuals are only infectious when they have symptoms, which can appear up to 21 days after exposure. Upon arrival to clinical setting/triage Assess the patient for a fever (subjective or  00.4°F / 38.0°C) Determine if the patient has symptoms compatible EVD such as headache, weakness, muscle Picture: an Electron Micrograph of the Ebola VirusCourtesy: Centers for Disease Control and Prevention 2009 Special Pathogens BranchDivision of HighConsequence Pathogens and PathologyNational Center Shoemaker T, MacNeil A, Balinandi S, Campbell S, Wamala J, McMullan LK, et al. Reemerging Sudan Ebola Virus Disease in Uganda, 2011. Emerg Infect Dis. 2012;18(9):1480-1483. https://doi.org/10.3201/eid1809.111536. And Influenza Preparedness. Jimmy Guidry, MD - DHH. January 20, 2015. Agenda Topics. Ebola Status Update: What has changed in West Africa that impacts EVD planning for US?. First Responder Update. Flu Season Update.